How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

When Not to Use Muscle Relaxants, How Frequent is Loneliness in RA/P…

RheumNow

J. Cush

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

TBC vs CBD in Rheumatoid Arthritis Patients: What Is The Latest Clin…

Daniel Arkfeld

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

CHEST 2022 Coverage

T. Kulkarni

Update in the Understanding and Management of Lupus

ARTHROS

M. Petri

Health Disparities in SLE

Hospital for Special Surgery

J. Yazdany

Dermatologic Manifestations in Rheumatic Diseases

Saakshi Khattri

Lupus Medication Management Tips: How to Manage the Side Effects of …

The Lupus Foundation, Philadelphia Tri-State Chapter

A. Askanase

Hurdles on the Way to Disease Modification in Lupus

ARTHROS

M. Petri

Top Shoulder Problems You See in the Office

UCSF School of Medicine

B. Feeley

2022 Updates on the Management of Lupus Nephritis

West Virginia State Rheumatology Society

M. Petri

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

S. Metyas

SLE Faculty Panel: Q&A at RheumNow Live! 2024

RheumNow

D. Karp, J. Michelle Kahlenberg, A. Fava

Interstitial Lung Disease in RA: RA-ILD Subtypes, Mortality Risk, RA…

RheumNow

J. Sparks, J. Cush

Methotrexate and the Gut Microbiome

RheumNow

R. Blank

Ever-Evolving Lupus Case & Cytopenias in SLE

Cleveland Clinic Rheumatology

E. Littlejohn

Systemic and Cutaneous Lupus Consideration

Masterclasses in Dermatology

J. Merola

The Window of Opportunity: Blockbuster Drugs, Opioids in Rheumatolog…

RheumNow

J. Cush